Abstract:The interest of Western medicine in Traditional Chinese Medicine（TCM） as a source of drug leads/new drugs to treat diseases without available efficient therapies has been dramatically augmented in the last decades by the extensive work and the outstanding findings achieved within this kind of medicine. The practice of TCM over thousands of years has equipped scientists with substantial experience with hundreds of plants that led to the discovery of artemisinin（qinghaosu）, which is extracted from the medicinal plant Artemisia annua L.（qinghao）. The unexpected success of artemisinin in combating malaria has drawn strong attention from the scientific community towards TCM. Artemisinin was discovered by Youyou Tu in 1972. Since then, several novel pharmacological activities based on the well-known properties of the sesquiterpene lactone structure with the oxepane ring and an endoperoxide bridge have been unravelled. Beyond malaria, artemisinin and its derivatives（artemisinins） exert profound activities towards other protozoans（Leishmania, Trypanosoma, amoebas, Neospora caninum, and Eimeria tenella）, trematodes（Schistosoma, liver flukes）, and viruses（human cytomegalovirus, hepatitis B and C viruses）. Less clear is the effect against bacteria and fungi. Based on the promising results of artemisinin and the first generation derivatives（artesunate, artemether, arteether）, novel drug development strategies have been pursued.These included the synthesis of acetal-and non-acetal-type artemisinin dimeric molecules as well as developing nanotechnological approaches, e.g.artemisinin-based liposomes, niosomes, micelles, solid lipid nanocarriers, nanostructured lipid carriers, nanoparticles, fullerenes and nanotubes. The current review presents an overview on different aspects of artemisinins, including sources, chemistry, biological/pharmacological properties, types of infectious pathogens that are susceptible to artemisinins in vitro and in vivo, in addition to the advancement in their drug delivery systems utilizing pharmaceutical technology. It would be expected that different therapeutic strategies based on the second and third generation artemisinin derivatives and artemisinin-based drug technologies would be available in the near future to treat specific infectious diseases.

Enhancing artemisinin content in and delivery from Artemisia annua: a review of alternative, classical, and transgenic approaches

Advanced metabolic engineering strategies for increasing artemisinin yield in Artemisia annua L

Biotechnological Approaches for Production of Artemisinin, an Anti-Malarial Drug from Artemisia annua L

From Plant to Yeast-Advances in Biosynthesis of Artemisinin

Increased Artemisinin Production by Promoting Glandular Secretory Trichome Formation and Reconstructing the Artemisinin Biosynthetic Pathway in Artemisia Annua

Transgenic Approach to Increase Artemisinin Content in Artemisia Annua L.

Increased artemisinin production in Artemisia annua L. by co-overexpression of six key biosynthetic enzymes

Cultivation and genetics of Artemisia annua L. for increased production of the antimalarial artemisinin

Molecular Farming in Artemisia annua, a Promising Approach to Improve Anti-malarial Drug Production

Selection and Clonal Propagation of High Artemisinin Genotypes of Artemisia annua

Molecular mechanism of artemisinin biosynthesis and regulation in Artemisia annua

Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties

Enhancement of Artemisinin Biosynthesis by Overexpressing Dxr, Cyp71av1 and Cpr in the Plants of Artemisia Annua L.

Combined chemical transformation and biological transformation of artemisinin: A facile approach to diverse artemisinin derivatives

Elevation of Artemisinin Content by Co-Transformation of Artemisinin Biosynthetic Pathway Genes and Trichome-Specific Transcription Factors in Artemisia Annua

Research progress on metabolic regulation of artemisinin

Metabolic Regulation and Engineering of Artemisinin Biosynthesis in A. Annua

Overexpression of the Cytochrome P450 Monooxygenase (cyp71av1) and Cytochrome P450 Reductase (cpr) Genes Increased Artemisinin Content in Artemisia Annua (Asteraceae).

Enhancement of Artemisinin Biosynthesis in Transgenic Artemisia Annua L. by Overexpressed HDR and ADS Genes

Enhancing artemisinin yields through an ecologically functional community of endophytes in Artemisia annua

Expanding the Therapeutic Spectrum of Artemisinin: Activity Against Infectious Diseases Beyond Malaria and Novel Pharmaceutical Developments